621例住院老老年心房颤动患者临床特点与抗凝现况分析

doi:10.3969/j.issn.1000-8535.2018.03.034

广州医药 ›› 2018, Vol. 49 ›› Issue (3): 117-119.DOI: 10.3969/j.issn.1000-8535.2018.03.034

621例住院老老年心房颤动患者临床特点与抗凝现况分析

刘稳, 张伟, 李桂芹, 邱智枫, 王丽

新疆石河子大学医学院第一附属医院心血管内科(石河子 832000)

收稿日期:2017-12-30 出版日期:2018-05-20 发布日期:2021-12-01
通讯作者: 王丽,E-mail:mcmwl@163.com

Clinical characteristics and antithrombotic status in 621 very elderly hospitalized patients with atrial fibrillation

LIU Wen, ZHANG Wei, LI Guiqin, QIU Zhifeng, WANG Li

Department of Cardiology, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832000, China

Received:2017-12-30 Online:2018-05-20 Published:2021-12-01

摘要/Abstract

摘要： 目的了解住院老老年心房颤动(atrial fibrillation,AF)患者的临床特征及抗凝现况。方法收集2015年6月—2017年9月住院老老年(≥80岁)房颤患者的抗凝用药,合并疾病,合并用药等临床信息,统计并分析,非正态分布的计量资料以中位数表示,采用秩和检验,两组计数资料采用χ²检验。结果 621例老老年患者根据性别分为男女两组,男354人,女267人,159例患者(25.6%)使用华法林,33例患者(5.31%)使用达比加群,30例患者(4.83%)使用利伐沙班,抗凝总人数为222例(35.75%)。174例患者(28.02%)使用阿司匹林,27例患者(4.35%)使用氯吡格雷,抗血小板总人数为201例(32.37%)。余198例患者(31.89%)未使用任何抗血小板或抗凝药物。结论老老年房颤患者目前抗凝率低,抗凝药物以华法林为主。

关键词: 老老年, 抗凝, 房颤, 阿司匹林, 华法林

Abstract: Objective This study investigated the clinical characteristics and antithrombotic status in elderly patients with atrial fibrillation AF. Methods In this study, we collected, analyzed and characterized the data of the patients hospitalized at the First Affiliated Hospital of Shihezi Medical University from June 2015 to September 2017. Results 621 cases of elderly patients were divided into two groups according to their gender between men and women, 159 patients (25.6%) take warfarin, 33 patients (5.31%) with dabigatran, 30 patients (4.83%) uses of rivaroxaban, the total number of anticoagulation is 222 (35.75%),174 patients (28.02%) were treated with aspirin, and 27 patients (4.35%) used clopidogrel, and the total number of antiplatelet agents was 201 (32.37%). 198 patients (31.89%) did not use any antiplatelet or anticoagulant drugs. Conclusion patients with atrial fibrillation anticoagulant rate is low, and the anticoagulant is mainly warfarin.

Key words: Senile, Anticoagulation, Atrial Fibrillation, Aspirin, Warfarin

刘稳, 张伟, 李桂芹, 邱智枫, 王丽. 621例住院老老年心房颤动患者临床特点与抗凝现况分析[J]. 广州医药, 2018, 49(3): 117-119.

LIU Wen, ZHANG Wei, LI Guiqin, QIU Zhifeng, WANG Li. Clinical characteristics and antithrombotic status in 621 very elderly hospitalized patients with atrial fibrillation[J]. Guangzhou Medical Journal, 2018, 49(3): 117-119.

[1]	郎吉萍, 戴秋月, 吕萍, 郭志刚. 阿司匹林抗结直肠癌的作用机制的生物信息学分析[J]. 广州医药, 2021, 52(6): 23-34.
[2]	田杏音, 万丽红, 黄秋媚, 彭斯晓, 郭新影, 赵井阳, 彭秋娇. 下肢DVT患者抗凝药服药知识、信念与依从性的调查研究[J]. 广州医药, 2021, 52(6): 133-137.
[3]	汪秀衡, 刘克皝, 刘垚, 胡恒境. I¹³¹联合TSH抑制治疗对术后中高危组甲状腺乳头状癌患者心肌纤维化及心房颤动的影响[J]. 广州医药, 2021, 52(4): 40-44.
[4]	李伟娜. 阿司匹林联合低分子肝素治疗高凝状态复发性流产的效果观察[J]. 广州医药, 2021, 52(2): 131-134.
[5]	杨诗琪, 王丽, 李岳明, 王楠. SAMe-TT₂R₂评分在非瓣膜性房颤患者抗凝疗效中的评估[J]. 广州医药, 2020, 51(2): 31-35.
[6]	银孟卓, 卢建文. 血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究[J]. 广州医药, 2018, 49(4): 13-16.
[7]	吴小燕, 陈婷, 秦琴保. 规范二级预防下老老年人轻型卒中复发危险因素分析[J]. 广州医药, 2016, 47(3): 61-63.
[8]	从毅, 金洪竹, 高鸿慈, 文齐. 阿司匹林在房颤抗凝治疗中的弱化[J]. 广州医药, 2015, 46(6): 90-91.
[9]	孙少喜, 雷晓明, 吕磊, 刘震, 彭健. 阵发性房颤环肺静脉电隔离术治疗对左心房结构和功能的影响[J]. 广州医药, 2015, 46(5): 56-57.
[10]	张勋梦, 孟庆奇, 王敏, 唐盛辉, 奉振成, 李斯明. 抗凝治疗对全膝关节表面置换术后疗效的影响[J]. 广州医药, 2015, 46(3): 19-21.

621例住院老老年心房颤动患者临床特点与抗凝现况分析

Clinical characteristics and antithrombotic status in 621 very elderly hospitalized patients with atrial fibrillation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价